Big Blu Broadband 93.5p GBP53.9m (LON:BBB)
The provider of alternative broadband services, announces that its subsidiary Quickline Communications Limited has won a competitive tender to provide fixed wireless access (“FWA”) and fibre to the premises broadband (“FTTP”) to premises in West Yorkshire and York that are unable to access fast and reliable internet connectivity of at least 30 megabits per second.
On behalf of the West Yorkshire Combined Authority, Quickline will enable 1,700 businesses in rural areas to connect to super-fast and, in most cases, ultra-fast broadband services whilst also passing a further 5,000 residential homes within two years. A number of premises will also be connected to full fibre networks providing for gigabit speeds.
The contract provides for a total investment of GBP9.11m in both fibre and fixed wireless networks, leading to significantly faster broadband speeds in the more isolated areas of West Yorkshire and York. The programme will receive a subsidy of GBP7.646m, with GBP6.898m funded from DEFRA, through the European Agricultural Fund for Rural Development and GBP748,000 from the Combined Authority. Quickline is also committing GBP1.464m of investment to support the roll-out.
Gama Aviation and Atkins, a member of the SNC-Lavalin Group, have been appointed by the Ministry of Defence (MOD) as the organisations responsible for supporting the airworthiness of the Viking T1 – the aircraft used by Royal Air Force (RAF) Air Cadets for basic glider training. The Viking is used at 10 locations across the UK to train Air Cadets to a sufficient standard for them to fly solo. The fleet currently comprises 48 gliders with four additional Vikings expected to be added to operations by the end of 2021. For the next two years, Gama Aviation and Atkins will support the airworthiness of the fleet, providing solutions to any issues that may arise around design standards and technical queries.
Kore Potash, the potash exploration and development company, reports that as a result of its close period ending, the Company’s significant shareholders, Sociedad Quimica y Minera de Chile S.A. (“SQM”), Princess Aurora Company Pte Ltd (“OIA”) and Chairman, David Hathorn, have confirmed their participation in the proposed fundraise announced on 26 August 2020 .
In addition, the Company has entered into the Technical Services Agreement with SQM for SQM to provide certain services to the Company (as described in the announcement on 25 August 2020).
Panoply Holdings 127.5p GBP71m (LON:TPX)
Acquisition of Difrent, a digital transformation consultancy focused on the Healthcare sector. The Acquisition is profitable and immediately earnings enhancing for The Panoply. Difrent has experienced significant growth in its consulting revenue over the last three years, and most recently reported unaudited revenues in its consulting division at GBP5.7m (2019: GBP3.2m) and unaudited EBITDA of GBP0.7m (2019: GBP0.1) for the year to 31 March 2020 (an increase of 78% and 600% respectively). Including its recruitment division Difrent delivered total unaudited revenue for the year to 31 March 2020 at GBP7.4m (2019: GBP4.3m) with unaudited EBITDA of GBP0.9m (2019: GBP0.2m) and unaudited profit after tax of GBP0.7m.
The Group has also entered into various agreements to amend the terms of a number of its historical share purchase agreements (“SPA”). In line with the Group’s strategy, as announced in its recent Annual Report, to consolidate its end-to-end propositions under two full stack brands, The Panoply has agreed to accelerate the end of the earn-out periods in respect of FutureGov and Ameo with a view facilitating full integration into the Group.
Silence Therapeutics 470.5p GBP390m (LON:SLN)
Research and Development Update
IND approval received for SLN360 to start dose escalation studies
Dosing initiated for SLN124, the first dose of a Silence GalNAc-siRNA given to humans.
Also announced today that U.S. SEC Declares Registration Statement Effective and NASDAQ Approves Listing of ADSs Representing Ordinary Shares. ADSs are expected to be listed for trading on such market under the symbol “SLN” on 8 September 2020.
7 digital Group 2.07p GBP50.9m (LON:7DIG)
The specialist in B2B end-to-end digital music solutions, has signed an initial 12-month contract with Apex Rides Limited, a cutting-edge high performance smart bike and in-home fitness platform, to service music for its virtual exercise classes.
In exclusive partnership with London-based boutique fitness pioneer Boom Cycle, new-to-market Apex provides a full home exercise connected bike and subscription service with live and on-demand interactive classes. With hardware pricing at a fraction of the leading market competitors and premium class content planned to attract and retain customers, Apex’s solution is designed as an accessible alternative for the mainstream market.
Good Energy 192p GBP32m (LON:GOOD)
The 100% renewable electricity supplier and innovative energy services provider, today announces that Zap – Map has launched an innovative new electric vehicle (“EV”) charging payment service. Zap-Map, the UK’s leading EV mapping service, has launched Zap-Pay, a new service that enables EV drivers to use a single app to pay for charging across different networks. Engenie, the UK wide rapid charging network, will be the first network available on Zap-Pay.
Ten Entertainment 137.5p GBP93.8m (LON:TEG)
Following the conclusion of a rigorous search for a new CEO, TEN announced the appointment, with immediate effect, of Graham Blackwell, initially as Interim Chief Executive Officer.
Graham is currently the Group’s Chief Operating Officer. He has over 30 years’ experience within this industry and has served on the Ten Entertainment Board since the IPO in 2017. His unique experience and outstanding execution skills make him ideally placed to lead the business through this next phase. Graham will continue to be supported by Antony Smith as CFO with guidance and oversight from Nick Basing, Interim Executive Chairman.
Following Graham’s appointment today, the Board has agreed that Duncan Garrood will step down from the Board and leave the business today, earlier than previously announced.
The Group has successfully re-opened 42 of its family entertainment centres. Three sites remain in local lockdown, and these are ready to open when local regulations allow. Initial trading has been very encouraging and is building week on week, proving to be cash generative already.
Synairgen 208p GBP311m (LON:SNG)
Positive data from interim analysis of SNG001 trial in COPD patients
– SNG001 well tolerated in this older population with a significant co-morbidity (COPD)
– Strong interferon driven antiviral biomarker response
– Data support future progression of SNG001 for exacerbating COPD patients
– Positive data supportive of SNG001 COVID-19 programme
Newmark Security 1.325p GBP6.2m (LON:NWT)
The provider of products and services in the security and data sectors, is pleased to announce that its wholly owned subsidiary Safetell Limited has secured new contracts with two existing clients.
Safetell has entered into a contract for the provision of services to one of its existing clients, a leading multinational financial services company. The two-year contract, which has an expected value of c. GBP1.3 million over the contract term, is for the provision of services to support the client’s security and asset protection systems in its nationwide branch network of over 500 locations. Safetell has also entered into a contract with another existing client, a leading UK building society. The three-year contract has an expected value of c. GBP400k for the Group and will include support for the client’s Auto Doors located at branch entrances.
Seeing Machines 4.05p GBP136.3m (LON:SEE)
The advanced computer vision technology company that designs AI-powered operator monitoring systems to improve transport safety, has signed a Memorandum of Understanding (MOU) with a global semiconductor company, as formal terms of engagement are finalised to license the Company’s OcculaTM Neural Processing Unit .
Targeting the expanding interior monitoring market for the automotive industry, this collaboration represents the third pillar of the Company’s recently launched Embedded Product Strategy which has been set out to license OcculaTM in ASIC form, to world-leading semiconductor companies for integration with any automotive compute platform.
OcculaTM is a custom accelerator designed for integration into ARM based SoC’s (System on Chip) for the purpose of accelerating Seeing Machines’ software and to support ultra low-power human face, eye and body tracking. Licensing OcculaTM to third party semiconductor companies creates additional pathways to automotive customers offering Driver
0203 764 2344
Status of this Note and Disclaimer
This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document is sent to you as market commentary only. As market commentary this document does not constitute any of (i) investment research and financial analysis or other forms of general recommendation relating to transactions in financial instruments for the purposes of section B of annex I to Directive 2014/65/EU (“MIFID II Directive”); or (ii) investment research as defined in article 36(1) of Commission Delegated Regulation 2017/565/EU made pursuant to the MIFID II Directive; or (iii) non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook).
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as “relevant persons”). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.